June 1, 2026: Over 100 Lawsuits in the GLP-1 NAION MDL, Ozempic Patient Sues After Becoming Blind from NAION The GLP-1 NAION multidistrict litigation now has 110 lawsuits in it, as of June 1, 2026
Glucagon-like peptide-1 (GLP-1) encourages the pancreas to release the right amount of insulin, slowing the bodys digestive rhythm, reducing appetite, and stabilizing blood sugar, all of which power the accomplishment of your medically-supported wellness goals without the expense of surgery or other invasive treatments
Start with a quick phone call where we happily & personally answer all your questions and arrange an in-office visit with one of our expert physicians
Take 2 capsules once daily.
Setting Realistic Weight Loss Goals With GLP-1 Therapy For athletes and highly active individuals, achieving a realistic weight loss goal requires more than intense workouts alone
They also may have specific symptoms based on where in the body the cancer cells have spread